Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects

NCT00909779 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

841

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Arformoterol
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.